“A Real Loss,” Expert Says Of Doomed ADAM Testing

The U.S. Justice Department’s closure of the Arrestee Drug Abuse Monitoring Program (ADAM) is a “a real loss,” Mark A. R. Kleiman, drug expert at the University of California, Los Angeles, told the New York Times. Kleiman, editor of The Drug Policy Analysis Bulletin, charged that “closing down ADAM indicates a complete lack of seriousness
Subscribe or log in to read the rest of this content.

Comments are closed.